center biologics evaluation research cber one six main centers us food drug administration fda part us department health human services current director cber peter marks md phd cber responsible assuring safety purity potency effectiveness biologics related products vaccines live biotherapeutics probiotics blood products cell tissue gene therapies biologics regulated cber monoclonal antibodies therapeutic proteins regulated fda center drug evaluation research cder july cbers authority resides sections public health service act various sections food drug cosmetic section public health service act requires licensure biological products travel interstate commerce united states cber may deny licensure suspend cancel current license manufacturer comply requirements unlicensed blood products used within boundaries state unusual products subject general regulations fda legal authoritiescitation needed section act allows surgeon general make enforce regulations control interstate spread communicable disease broad authority delegated fda memorandum understanding many products overseen cber also considered drugs subject rules regulations drug product food drug cosmetic actcitation needed legal authorities cber publishes regulations included first chapter title code federal regulations regulations specific cber found contains rules hctps products also drugs blood transfusion rules following apply general rules regulations clinical trials involving human subjects may also applycitation needed addition laws guidelines cber also publishes guidance documents requirements generally followed industry licensed manufacturers expected adopt either guidance equivalent process cases guidance documents force regulation written clarify existing rulescitation needed vaccine adverse event reporting system based data integration platform informatica fda uses software analyze data adverse reactions vaccines biological order improve cbers vaccines related biological products advisory committee meets annually discussion vote concerning next years influenza vaccine virus according numbers fda cber reviewed biologics license applications blas median review time months median approval time cbers history began horse named jim vaccinecontamination scandal prompted biologics control act originally cber part became national institutes health rather mission included mandate foster development new bureau transferred nih fda renamed bureau biologics focused vaccines serums allergy shots blood ten years later beginning biotechnology revolution line drug biologic device biologic became merged fdas bureau drugs form center drugs biologics agencywide reorganization commissioner arthur reorganization similarly merged bureaus responsible medical devices radiation control center devices radiological health commissioner frank young cber center drug evaluation research cder split present two groups charged enforcing different laws significantly different philosophical cultural cber took collaborative publichealth driven approach working industry quicker approve products drugs growing crisis around hiv testing treatment interagency dispute officials former bureau drugs officials former bureau biologics whether approve genentechs activase tissue plasminogen activator led split cber declared primary agency hivaidsrelated products since hiv spread significantly blood transfusion related congress reauthorized user fees research previously done taxpayer expense began charged cbers research work diminished dramatically since fda transferred number biologically produced therapeutics cber regulates number biologicsrelated products including blood tests computer software devices related blood transfusion industry representatives would like see handled much brisker center devices radiological federal law dhs policy define procedures cber establish advisory may divided panels must renewed every two fda advisory committees pandemic vaccines related biological products advisory committee vrbpac received media attention reviewed vaccines approvalcitation needed httpsenwikipediaorgwikicenterforbiologicsevaluationandresearch